Plus US facility to be operational in the "next month or so" and expecting a forthcoming order for 1 new Arcemy unit pre EOY. Assume will add $1-2M to the current expected FY 2025 revenue.
Agreed, highlighting the $40M in sales opportunities was a bit surprising. Must be pretty confident on getting a significant proportion if these sales to mention this value. Otherwise will be quite embarrassing if evidence of conversion into contract is not seen during FY2025.
Even getting "just" 25% of these is a cool $10M in contracts. Still a large number for AML3D at this stage.
Very surprised there is zero movement in the share price.
Know many will want to see the actual contracts landed first and some evidence of business moving closer to break even.
Maybe we need to wait for NextInvestors to publish their next puff piece highlighting the sales opportunities pipeline.
AL3 Price at posting:
19.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)